The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Grant | Alive

About CureImmune

CureImmune is developing an immuno-oncology checkpoint inhibitor drug that is a stable small molecule, inexpensive to manufacture, easy to store and ship, and that can be administered at home.

CureImmune Headquarter Location

Fitzsimmons Bioscience Center 12635 E. Montview Blvd. Suite 100G

Aurora, Colorado, 80045,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CureImmune

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CureImmune is included in 1 Expert Collection, including Cancer.



4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

  • Where is CureImmune's headquarters?

    CureImmune's headquarters is located at Fitzsimmons Bioscience Center, Aurora.

  • What is CureImmune's latest funding round?

    CureImmune's latest funding round is Grant.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.